Why the study?
Does a blocker of the endothelin type A receptor prevent myocardial infarction in hypercholesterolemic apolipoprotein E-/- low density lipoprotein receptor-/- mice exposed to stress or hypoxia?
Does a blocker of the endothelin type A receptor prevent myocardial infarction in hypercholesterolemic apolipoprotein E-/- low density lipoprotein receptor-/- mice exposed to stress or hypoxia?
Endothelin type A receptor blockade prevents stress-induced myocardial infarction in a hypercholesterolemic mouse model of coronary atherosclerosis.
Answers are grounded in this paper and cite their sources.
ET_A receptor blockade may protect against stress-induced myocardial injury in atherosclerotic mice; leaves open any human translation or clinical testing.
Myocardial infarction is linked to atherosclerosis, yet the sequence leading from silent coronary atherosclerosis to acute myocardial infarction has remained unclear. Here we show that hypercholesterolemic apolipoprotein E-/- low density lipoprotein receptor-/- mice develop not only coronary atherosclerosis but also myocardial infarction. Exposure of mice to mental stress or hypoxia led to acute ischemia, which, in a large proportion of the mice, was followed by electrocardiographic changes, leakage of troponin T, and loss of dehydrogenase from the myocardium, all indicative of acute myocardial infarction. Apoptotic death of cardiomyocytes was followed by inflammation and fibrosis in the heart. All these pathological changes could be prevented by a blocker of the endothelin type A receptor. Thus, stress elicits myocardial infarction through endothelin receptor signaling in coronary atherosclerosis caused by hypercholesterolemia.
No takes yet. Share an insight, caveat, or question.
Caligiuri et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: